MarketPeel
Insider Trading Intelligence
SD

Simon Dumesnil

KTTA
DIRECTOR · PASITHEA THERAPEUTICS CORP. · CIK 0001875691
FILING MIX · LIFETIME100%/0%
BUYS
8
SELLS
0
TOTAL VALUE
$78.1K
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
152,783
AVG SELL PX
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Simon Dumesnil, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-23.13%+0.34%-23.47%-23.47%
14d1+0.00%-23.13%-0.24%-22.89%-22.89%
30d1+0.00%-22.45%+0.65%-23.10%-23.10%
60d1+0.00%-42.38%+1.77%-44.15%-44.15%
90d1+0.00%-42.99%+0.86%-43.86%-43.86%
180d1+0.00%-53.73%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KTTA · 152,783 shares · as of May 1, 2026
038,19676,392114,587152,78320222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 8 buys / 0 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
152,783152,783May 1, 2026May 5, 2026View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASE
33,333$0.75$25.0K35,833Nov 28, 2025Dec 1, 2025View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
42,91342,913Oct 24, 2025Oct 27, 2025View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
7,5007,500Mar 1, 2024Apr 5, 2024View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
7,5007,500Mar 1, 2024Mar 1, 2024View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
40,000$1.06$42.4K50,000Nov 17, 2022Nov 17, 2022View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
10,000$1.07$10.7K10,000Nov 15, 2022Nov 17, 2022View →
KTTA
PASITHEA THERAPEUTICS CORP.
PURCHASEGRANT
Stock grant
100,000100,000Aug 2, 2021Nov 17, 2022View →
Other insiders · KTTA
Loading peer insiders…
About this filer
CIK 0001875691
ROLE
Director
PRIMARY
KTTA
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001875691DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback